What is Precigen Inc's earnings per share (EPS)?

Precigen Inc (PGEN) reported diluted earnings per share of $-1.37 for fiscal year 2025. This represents a -191.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Precigen Inc Financials

PGEN

Source SEC Filings (10-K/10-Q) Updated Mar 25, 2026 Currency USD FYE March

This page shows Precigen Inc (PGEN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 14/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Precigen Inc has an operating margin of -6078.5%, meaning the company retains $-6078 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage

Precigen Inc has elevated debt relative to equity (D/E of 4.46), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 11/100, reflecting increased financial risk.

Liquidity

Precigen Inc's current ratio of 3.09 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Precigen Inc generated -$87.8M in operating cash flow, capex of $2.0M consumed most of it, leaving -$89.8M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Precigen Inc generates a -1198.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -327.8% the prior year.

Piotroski F-Score Weak

1/9

Precigen Inc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.35x

For every $1 of reported earnings, Precigen Inc generates $0.35 in operating cash flow (-$87.8M OCF vs -$250.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-28.6x

Precigen Inc earns $-28.6 in operating income for every $1 of interest expense (-$110.5M vs $3.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.8M

5Y CAGR-43.6%

10Y CAGR-36.6%

Precigen Inc generated $1.8M in revenue in fiscal year 2025.

EBITDA

-$107.3M

Precigen Inc's EBITDA was -$107.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

-$250.6M

YoY-98.6%

Precigen Inc reported -$250.6M in net income in fiscal year 2025. This represents a decrease of 98.6% from the prior year.

EPS (Diluted)

$-1.37

YoY-191.5%

Precigen Inc earned $-1.37 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 191.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$89.8M

YoY-17.0%

Precigen Inc generated -$89.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 17.0% from the prior year.

Cash & Debt

$30.2M

YoY+2.4%

5Y CAGR-10.2%

10Y CAGR-13.9%

Precigen Inc held $30.2M in cash against $93.2M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

354M

YoY+20.8%

5Y CAGR+13.5%

10Y CAGR+11.7%

Precigen Inc had 354M shares outstanding in fiscal year 2025. This represents an increase of 20.8% from the prior year.

Margins & Returns

Gross Margin

-165.3%

10Y CAGR-241.8pp

Precigen Inc's gross margin was -165.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

-6078.5%

10Y CAGR-5993.9pp

Precigen Inc's operating margin was -6078.5% in fiscal year 2025, reflecting core business profitability.

Net Margin

-13786.7%

5Y CAGR-13253.7pp

10Y CAGR-13738.0pp

Precigen Inc's net profit margin was -13786.7% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity

-1198.6%

YoY-870.8pp

5Y CAGR-944.8pp

10Y CAGR-1186.4pp

Precigen Inc's ROE was -1198.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 870.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$41.3M

10Y CAGR-11.9%

Precigen Inc invested $41.3M in research and development in fiscal year 2025.

Share Buybacks

N/A

Capital Expenditures

$2.0M

YoY-76.8%

5Y CAGR-23.3%

10Y CAGR-16.9%

Precigen Inc invested $2.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 76.8% from the prior year.

PGEN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.8M	N/A	N/A	$26.9M+88.6%	$14.3M-55.4%	$32.0M
Cost of Revenue	$4.8M	N/A	N/A	N/A	N/A	N/A
Gross Profit	-$3.0M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$41.3M	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$70.1M	N/A	N/A	N/A	N/A	N/A
Operating Income	-$110.5M	N/A	N/A	N/A	N/A	N/A
Interest Expense	$3.9M	N/A	N/A	N/A	N/A	N/A
Income Tax	$3K+100.2%	-$1.8M-291.5%	-$458K-142.3%	-$189K-18.1%	-$160K-95.1%	-$82K
Net Income	-$250.6M-98.6%	-$126.2M-31.6%	-$95.9M-438.7%	$28.3M+130.7%	-$92.2M+46.0%	-$170.5M
EPS (Diluted)	$-1.37-191.5%	$-0.47-20.5%	$-0.39-378.6%	$0.14+129.8%	$-0.47+53.9%	$-1.02

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0-100.0%	$3K	$0	N/A	$12K+100.7%	-$1.7M-5724.1%	-$29K	N/A
Net Income	-$146.3M-449.3%	-$26.6M+50.8%	-$54.2M	N/A	-$24.0M+59.2%	-$58.8M-147.7%	-$23.7M	N/A
EPS (Diluted)	$-1.06-1077.8%	$-0.09+50.0%	$-0.18	N/A	$-0.09+60.9%	$-0.23-130.0%	$-0.10	N/A

PGEN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$155.5M+7.0%	$145.3M-3.8%	$151.0M-30.1%	$216.0M-40.0%	$359.9M+14.4%	$314.6M
Current Assets	$115.2M+12.5%	$102.4M+49.0%	$68.8M-41.8%	$118.2M-24.6%	$156.6M+5.2%	$148.9M
Cash & Equivalents	$30.2M+2.4%	$29.5M+289.5%	$7.6M+56.0%	$4.9M-86.7%	$36.4M-29.7%	$51.8M
Inventory	$172K	$0	N/A	N/A	N/A	N/A
Accounts Receivable	$3.9M+322.9%	$926K+2.7%	$902K-7.8%	$978K-27.1%	$1.3M-91.9%	$16.5M
Goodwill	$15.2M-20.4%	$19.1M-28.1%	$26.6M-27.9%	$36.9M-1.7%	$37.6M-30.9%	$54.4M
Total Liabilities	$134.6M+71.4%	$78.5M+141.3%	$32.5M-63.7%	$89.7M-64.5%	$252.5M+2.1%	$247.4M
Current Liabilities	$37.3M+73.4%	$21.5M-6.4%	$23.0M-70.8%	$78.6M+127.0%	$34.6M-17.8%	$42.1M
Long-Term Debt	$93.2M	$0	N/A	$0-100.0%	$179.9M+4.9%	$171.5M
Total Equity	$20.9M-45.7%	$38.5M-67.5%	$118.5M-6.1%	$126.3M+17.6%	$107.3M+59.8%	$67.2M
Retained Earnings	-$2.3B-12.0%	-$2.1B-6.4%	-$2.0B-5.1%	-$1.9B+2.5%	-$1.9B-5.1%	-$1.8B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$171.3M+68.1%	$101.9M-20.9%	$128.8M-11.3%	$145.3M+74.0%	$83.5M+14.1%	$73.2M-45.7%	$134.8M-10.7%	$151.0M
Current Assets	$129.6M+106.5%	$62.8M-25.8%	$84.6M-17.4%	$102.4M+196.7%	$34.5M+45.5%	$23.7M-52.1%	$49.5M-27.9%	$68.8M
Cash & Equivalents	$14.3M+4.1%	$13.8M+127.1%	$6.1M-79.5%	$29.5M+19.4%	$24.7M+164.6%	$9.3M-46.5%	$17.5M+130.6%	$7.6M
Inventory	$47K	N/A	N/A	$0	N/A	N/A	N/A	N/A
Accounts Receivable	$580K+77.4%	$327K-56.5%	$751K-18.9%	$926K+93.3%	$479K-6.3%	$511K-41.4%	$872K-3.3%	$902K
Goodwill	$15.2M0.0%	$15.2M-20.4%	$19.1M0.0%	$19.1M-23.2%	$24.9M0.0%	$24.9M-6.2%	$26.6M-0.2%	$26.6M
Total Liabilities	$129.4M-6.7%	$138.7M-2.9%	$142.8M+81.9%	$78.5M+179.5%	$28.1M-6.3%	$30.0M-20.7%	$37.8M+16.2%	$32.5M
Current Liabilities	$32.1M+38.3%	$23.2M-3.3%	$24.0M+11.5%	$21.5M+1.4%	$21.2M-7.8%	$23.0M-20.0%	$28.8M+25.2%	$23.0M
Long-Term Debt	$92.9M	N/A	N/A	$0	N/A	N/A	N/A	N/A
Total Equity	$41.9M+213.8%	-$36.8M-161.6%	-$14.1M-136.5%	$38.5M-30.5%	$55.4M+28.3%	$43.2M-55.5%	$97.0M-18.1%	$118.5M
Retained Earnings	-$2.3B-6.7%	-$2.2B-1.2%	-$2.1B-2.6%	-$2.1B-1.0%	-$2.1B-1.2%	-$2.0B-3.0%	-$2.0B-1.2%	-$2.0B

PGEN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$87.8M-28.8%	-$68.2M-1.9%	-$66.9M-2.9%	-$65.0M-16.6%	-$55.8M+27.6%	-$77.0M
Capital Expenditures	$2.0M-76.8%	$8.6M+458.9%	$1.5M-68.8%	$4.9M-32.1%	$7.2M-3.7%	$7.5M
Free Cash Flow	-$89.8M-17.0%	-$76.8M-12.1%	-$68.5M+2.1%	-$70.0M-11.0%	-$63.0M+25.5%	-$84.5M
Investing Cash Flow	-$1.5M+92.6%	-$20.7M-571.0%	-$3.1M-101.4%	$226.4M+403.8%	-$74.5M-368.3%	$27.8M
Financing Cash Flow	$90.0M-18.6%	$110.6M+273.7%	$29.6M+119.1%	-$155.3M-228.1%	$121.2M+270.5%	$32.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$29.1M-53.2%	-$19.0M-16.2%	-$16.3M-98.0%	-$8.2M+63.7%	-$22.7M+1.6%	-$23.1M-64.0%	-$14.1M+10.6%	-$15.8M
Capital Expenditures	$389K-59.7%	$966K+55.3%	$622K-39.5%	$1.0M+16.6%	$882K-62.0%	$2.3M-46.6%	$4.4M+316.4%	$1.0M
Free Cash Flow	-$29.5M-47.7%	-$19.9M-17.7%	-$16.9M-82.8%	-$9.3M+60.7%	-$23.6M+7.1%	-$25.4M-37.9%	-$18.4M-9.7%	-$16.8M
Investing Cash Flow	-$63.4M-322.9%	$28.4M+540.5%	-$6.5M+90.1%	-$65.4M-1256.3%	$5.7M-62.2%	$15.0M-37.8%	$24.0M+80.9%	$13.3M
Financing Cash Flow	$93.0M+5366.5%	-$1.8M-160.1%	-$679K-100.9%	$78.4M+144.0%	$32.1M+61682.7%	$52K	$0	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PGEN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	-165.3%	N/A	N/A	N/A	N/A	N/A
Operating Margin	-6078.5%	N/A	N/A	N/A	N/A	N/A
Net Margin	-13786.7%	N/A	N/A	105.2%+751.2pp	-646.0%-113.0pp	-533.0%
Return on Equity	-1198.6%-870.8pp	-327.8%-246.8pp	-80.9%-103.4pp	22.4%+108.3pp	-85.9%+168.0pp	-253.8%
Return on Assets	-161.2%-74.3pp	-86.9%-23.4pp	-63.5%-76.6pp	13.1%+38.7pp	-25.6%+28.6pp	-54.2%
Current Ratio	3.09-1.7	4.76+1.8	2.99+1.5	1.50-3.0	4.52+1.0	3.54
Debt-to-Equity	4.46+4.5	0.00-0.3	0.27+0.3	0.00-1.7	1.68-0.9	2.55
FCF Margin	-4940.9%	N/A	N/A	-260.0%+181.7pp	-441.7%-177.4pp	-264.3%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-349.5%	N/A	N/A	N/A	-43.3%+92.9pp	-136.2%-111.7pp	-24.5%	N/A
Return on Assets	-85.5%-59.3pp	-26.2%+15.9pp	-42.0%	N/A	-28.7%+51.6pp	-80.4%-62.8pp	-17.6%	N/A
Current Ratio	4.04+1.3	2.71-0.8	3.53-1.2	4.76+3.1	1.63+0.6	1.03-0.7	1.72-1.3	2.99
Debt-to-Equity	2.22+6.0	-3.77+6.4	-10.16-10.2	0.00-0.5	0.51-0.2	0.69+0.3	0.39+0.1	0.27
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Zymeworks ZYME

$1.9B

Arcus Bioscience RCUS

$2.9B

Structure Therapeutics Inc ADR GPCR

$3.8B

Intellia Therape NTLA

$1.6B

Tourmaline Bio TRML

$1.2B

Frequently Asked Questions

What is Precigen Inc's annual revenue?

Precigen Inc (PGEN) reported $1.8M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Precigen Inc profitable?

No, Precigen Inc (PGEN) reported a net income of -$250.6M in fiscal year 2025, with a net profit margin of -13786.7%.

What is Precigen Inc's EBITDA?

Precigen Inc (PGEN) had EBITDA of -$107.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Precigen Inc have?

As of fiscal year 2025, Precigen Inc (PGEN) had $30.2M in cash and equivalents against $93.2M in long-term debt.

What is Precigen Inc's gross margin?

Precigen Inc (PGEN) had a gross margin of -165.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Precigen Inc's operating margin?

Precigen Inc (PGEN) had an operating margin of -6078.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Precigen Inc's net profit margin?

Precigen Inc (PGEN) had a net profit margin of -13786.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Precigen Inc's return on equity (ROE)?

Precigen Inc (PGEN) has a return on equity of -1198.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Precigen Inc's free cash flow?

Precigen Inc (PGEN) generated -$89.8M in free cash flow during fiscal year 2025. This represents a -17.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Precigen Inc's operating cash flow?

Precigen Inc (PGEN) generated -$87.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Precigen Inc's total assets?

Precigen Inc (PGEN) had $155.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Precigen Inc's capital expenditures?

Precigen Inc (PGEN) invested $2.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Precigen Inc spend on research and development?

Precigen Inc (PGEN) invested $41.3M in research and development during fiscal year 2025.

How many shares does Precigen Inc have outstanding?

Precigen Inc (PGEN) had 354M shares outstanding as of fiscal year 2025.

What is Precigen Inc's current ratio?

Precigen Inc (PGEN) had a current ratio of 3.09 as of fiscal year 2025, which is generally considered healthy.

What is Precigen Inc's debt-to-equity ratio?

Precigen Inc (PGEN) had a debt-to-equity ratio of 4.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Precigen Inc's return on assets (ROA)?

Precigen Inc (PGEN) had a return on assets of -161.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Precigen Inc's cash runway?

Based on fiscal year 2025 data, Precigen Inc (PGEN) had $30.2M in cash against an annual operating cash burn of $87.8M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Precigen Inc's Piotroski F-Score?

Precigen Inc (PGEN) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Precigen Inc's earnings high quality?

Precigen Inc (PGEN) has an earnings quality ratio of 0.35x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Precigen Inc cover its interest payments?

Precigen Inc (PGEN) has an interest coverage ratio of -28.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Precigen Inc?

Precigen Inc (PGEN) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.